期刊文献+

浆液性卵巢癌发生学及其遗传学机制研究进展 被引量:2

下载PDF
导出
摘要 卵巢癌是女性生殖系统肿瘤中死亡率最高的肿瘤,其发生学和自然史仍未阐明。浆液性卵巢癌是最常见的卵巢恶性肿瘤,近年大量临床病理学和分子生物学研究提示,浆液性卵巢癌的发生存在二元论模型:低分级浆液性卵巢癌发生存在多步骤过程,有前体病变;高分级浆液性卵巢癌则直接起源于卵巢表面上皮或包涵囊肿,缺乏前体病变。不同分级浆液性卵巢癌存在不同的形态学和遗传学特征。二元论模型为今后研究上皮性卵巢癌发生机制提供了蓝图。
出处 《国外医学(妇产科学分册)》 2006年第4期253-256,共4页 Foreign Medical Sciences(Obstet Gynecol Fascicle)
  • 相关文献

参考文献19

  • 1Singer G,Kurman RJ,Chang HW,et al.Diverse tumorigenic pathways in ovarian serous carcinoma.Am J Pathol,2002,160(4):1223-1228
  • 2Smith Sehdev AE,Sehdev PS,Kurman RJ.Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary:a clinicopathologic analysis of 135 cases.Am J Surg Pathol,2003,27(6):725-736
  • 3Malpica A,Deavers MT,Lu K,et al.Grading ovarian serous carcinoma using a two-tier system.Am J Surg Pathol,2004,28(4):496-504
  • 4Horiuchi A,Itoh K,Shimizu M,et al.Toward understanding the natural history of ovarian carcinoma development:a clinicopathological approach.Gynecol Oncol,2003,88(3):309-317
  • 5Singer G,Oldt R,Cohen Y,et al.Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.J Natl Cancer Inst,2003,95(6):484-486
  • 6Cheng EJ,Kurman RJ,Wang M,et al.Molecular genetic analysis of ovarian serous cystadenomas.Lab Invest,2004,84(6):778-784
  • 7Ho CL,Kurman RJ,Dehari R,et al.Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors.Cancer Res,2004,64(19):6915-6918
  • 8Singer G,Shih IeM,Truskinovsky A,et al.Mutational analysis of Kras segregates ovarian serous carcinomas into two types:invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor).Int J Gynecol Pathol,2003,22(1):37-41
  • 9Hsu CY,Bristow R,Cha MS,et al.Characterization of active mitogenactivated protein kinase in ovarian serous carcinomas.Clin Cancer Res,2004,10(19):6432-6436
  • 10Pothuri B,Leitao M,Barakat R,et al.Genetic analysis of ovarian carcinoma histogenesis.Gynecol Oncol,2001,80(2):277

同被引文献33

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2席稳燕,高英敏.HIF1α、Glut1在子宫内膜癌中的表达及其临床意义[J].现代妇产科进展,2006,15(3):195-198. 被引量:10
  • 3廖冰,薛玲,车丽洪,吴惠茜.p53、p21^(ras)和connexin43蛋白在卵巢浆液性囊腺癌中的表达及意义[J].临床与实验病理学杂志,2006,22(4):498-499. 被引量:8
  • 4任凤岩,张淑兰,姜彦多,王丹波.卵巢子宫内膜样癌及其合并子宫内膜异位症的临床及病理分析[J].中国实用妇科与产科杂志,2007,23(9):708-709. 被引量:18
  • 5Malpica A, Deavers MT, Lu K, et al. Grading ovarian serous carcinoma using a two - tier system [ J ~. Am J Surg Pathol, 2004,28 ( 4 ) :496 - 504.
  • 6O' Neill CJ,Deavers MT, Malpica A,et al. Animmuno- histochemical comparison between low - grade and high- grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER - 2/neu, and C - KIT in high - grade neoplasms [ J]. Am J Surg Patho1,2005,29( 8 ) : 1034 - 1041.
  • 7Minamoto T, Mai M, Ronai Z. K - ras mutation early detection in molecular diagnosis and risk and assess- ment of colorectal pancreas and lung cancers [ J ]. Cancer Detect Prey ,2000,24( 1 ) :1 - 12.
  • 8Chan WY, Cheung KK, Schorge JO, et al. Bcl -2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers [ J ]. Am J Pathol, 2000,156(2) :409 -417.
  • 9O'Neill C J, Deavers MT, Malpica A, et al. An im- munohistochemical comparison between low - grade and high - grade ovarian serous carcinomas: signifi- cantly higher expression of p53, MIB1, BCL2, HER'- 2neu, and C - KIT in high - grade neoplasms [J]. Am J Surg Pathol ,2005,29:1034 - 1041.
  • 10Shil Ie M, Kurman RJ. Ovarian tumorigenesis:a pro- posed model based on morphological and molecular ge- netic analysis [ J ]. Am J Pathol, 2004, 164 ( 5 ) : 1511 -1518.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部